Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
2.700
-0.160 (-5.59%)
Dec 20, 2024, 4:00 PM EST - Market closed
Skye Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 82 | 34 | 15 | 25 | 11 | 19 | |
| Market Cap Growth | 135.06% | 126.97% | -40.22% | 130.88% | -42.17% | -65.37% | |
| Enterprise Value | 15 | 33 | 17 | 16 | 8 | 21 | |
| Last Close Price | 2.70 | 2.72 | 4.05 | 13.00 | 10.00 | 32.63 | |
| PE Ratio | - | - | - | - | - | 17.63 | |
| PB Ratio | 1.08 | -15.76 | -4.92 | 4.22 | 23.79 | 33.83 | |
| P/TBV Ratio | 1.56 | - | - | 4.22 | 23.79 | 33.83 | |
| Debt / Equity Ratio | 0.00 | -2.16 | -0.66 | 0.36 | 3.32 | 0.71 | |
| Quick Ratio | 11.99 | 0.14 | 0.12 | 2.30 | 3.14 | 1.88 | |
| Current Ratio | 14.19 | 0.84 | 0.74 | 2.46 | 3.38 | 2.05 | |
| Return on Equity (ROE) | -54.82% | - | -1364.20% | -269.90% | -1313.66% | - | |
| Return on Assets (ROA) | -30.39% | -80.28% | -120.69% | -78.31% | -168.39% | -209.69% | |
| Return on Capital (ROIC) | -35.95% | -1159.18% | -328.19% | -98.60% | -272.61% | - | |
| Earnings Yield | -25.93% | -112.07% | -131.64% | -34.42% | -61.18% | 5.67% | |
| FCF Yield | -27.43% | -41.57% | -86.75% | -26.52% | -56.53% | -32.51% | |
| Buyback Yield / Dilution | -537.83% | -215.43% | -36.56% | -75.70% | -36.48% | -39.95% | |
| Total Shareholder Return | -537.83% | -215.43% | -36.56% | -75.70% | -36.48% | -39.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.